METFORMIN REDUCES CISPLATIN-MEDIATED APOPTOSIS IN GASTRIC ADENOCARCINOMA CELLS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SALARAMOLI J.; GHAFFARI H.; HEIDARI M.; LESAN V.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Feyz Medical Sciences Journal Year:2013 | Volume:17 | Issue:2 Page(s): 139-148

Download Full-Text

Persian Verion

View:

784

Download:

Cites:

Information Journal Paper

Title

METFORMIN REDUCES CISPLATIN-MEDIATED APOPTOSIS IN GASTRIC ADENOCARCINOMA CELLS

Author(s)

SALARAMOLI J. | GHAFFARI H. | HEIDARI M. | LESAN V. | Issue Writer Certificate

Keywords

METFORMINQ2

CISPLATINQ2

MKN45 CELL LINEQ2

SURVIVINQ2

AKTQ2

Abstract

Background: METFORMIN, a drug widely used for type 2 diabetes, may also have anti-cancer properties. The purpose of this study was to examine the effect of METFORMIN on CISPLATIN cytotoxicity in the gastric adenocarcinoma cells line (MKN45).Materials and Methods: In this study, cells viability and apoptosis were measured using the (3- [4, 5-dimethylthiazol-2-yl] -2, 5-diphenyltetrazolium bromide) assay and flow cytometry, respectively. Moreover, the expressions of mammalian target of rapamycin, SURVIVIN and AKT genes were evaluated by RT-PCR. All experiments were performed in triplicate.Results: The results showed that each of METFORMIN and CISPLATIN separately reduced the viability of cancer cell, but in co-administration, METFORMIN reduced the cytotoxicity of CISPLATIN. In co-administration, the SURVIVIN expression was increased followed by a reduction in CISPLATIN anti-cancer effect. Therefore, the antagonistic effect of drugs can be associated with SURVIVIN expression. The results also revealed that the anti-apoptotic effects of METFORMIN co-administrated with CISPLATIN are associated with increased AKT expression.Conclusion: It seems that in gastric cancers, METFORMIN is not an appropriate choice to make cells sensitive to CISPLATIN and the antagonistic effects of the two drugs should be considered when they prescribed in combination.

Cites

No record.

References

Cite

APA: Copy

SALARAMOLI, J., GHAFFARI, H., HEIDARI, M., & LESAN, V.. (2013). METFORMIN REDUCES CISPLATIN-MEDIATED APOPTOSIS IN GASTRIC ADENOCARCINOMA CELLS. FEYZ, 17(2), 139-148. SID. https://sid.ir/paper/40978/en

Vancouver: Copy

SALARAMOLI J., GHAFFARI H., HEIDARI M., LESAN V.. METFORMIN REDUCES CISPLATIN-MEDIATED APOPTOSIS IN GASTRIC ADENOCARCINOMA CELLS. FEYZ[Internet]. 2013;17(2):139-148. Available from: https://sid.ir/paper/40978/en

IEEE: Copy

J. SALARAMOLI, H. GHAFFARI, M. HEIDARI, and V. LESAN, “METFORMIN REDUCES CISPLATIN-MEDIATED APOPTOSIS IN GASTRIC ADENOCARCINOMA CELLS,” FEYZ, vol. 17, no. 2, pp. 139–148, 2013, [Online]. Available: https://sid.ir/paper/40978/en

Related Journal Papers